BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 22355504)

  • 1. Successful radiotherapy for local control of progressively increasing metastasis of gastrointestinal stromal tumor.
    Lolli C; Pantaleo MA; Nannini M; Saponara M; Pallotti MC; Scioscio VD; Barbieri E; Mandrioli A; Biasco G
    Rare Tumors; 2011 Oct; 3(4):e49. PubMed ID: 22355504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surgery for metastatic gastrointestinal stromal tumor: to whom and how to?
    Kikuchi H; Hiramatsu Y; Kamiya K; Morita Y; Sakaguchi T; Konno H; Takeuchi H
    Transl Gastroenterol Hepatol; 2018; 3():14. PubMed ID: 29682621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiotherapy in the management of gist: state of the art and new potential scenarios.
    Gatto L; Nannini M; Saponara M; Di Scioscio V; Beltramo G; Frezza GP; Ercolani G; Pinna AD; Astolfi A; Urbini M; Brandi G; Biasco G; Pantaleo MA
    Clin Sarcoma Res; 2017; 7():1. PubMed ID: 28078078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiotherapy in the treatment of gastrointestinal stromal tumor.
    Knowlton CA; Brady LW; Heintzelman RC
    Rare Tumors; 2011 Oct; 3(4):e35. PubMed ID: 22355490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imatinib mesylate: in the treatment of gastrointestinal stromal tumours.
    Croom KF; Perry CM
    Drugs; 2003; 63(5):513-22; discussion 523-4. PubMed ID: 12600228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tyrosine kinase inhibitors in the treatment of unresectable or metastatic gastrointestinal stromal tumors.
    Nishida T; Doi T; Naito Y
    Expert Opin Pharmacother; 2014 Oct; 15(14):1979-89. PubMed ID: 24990162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytoreductive Surgery for Metastatic Gastrointestinal Stromal Tumors Treated With Tyrosine Kinase Inhibitors: A 2-institutional Analysis.
    Fairweather M; Balachandran VP; Li GZ; Bertagnolli MM; Antonescu C; Tap W; Singer S; DeMatteo RP; Raut CP
    Ann Surg; 2018 Aug; 268(2):296-302. PubMed ID: 28448384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gastrointestinal stromal tumors: imatinib and beyond.
    Schnadig ID; Blanke CD
    Curr Treat Options Oncol; 2006 Nov; 7(6):427-37. PubMed ID: 17032555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost effectiveness of tyrosine kinase inhibitor therapy in metastatic gastrointestinal stromal tumors.
    Blanke CD; Huse DM
    J Med Econ; 2010; 13(4):681-90. PubMed ID: 21067355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downsizing treatment with tyrosine kinase inhibitors in patients with advanced gastrointestinal stromal tumors improved resectability.
    Sjölund K; Andersson A; Nilsson E; Nilsson O; Ahlman H; Nilsson B
    World J Surg; 2010 Sep; 34(9):2090-7. PubMed ID: 20512492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of Gastrointestinal Stromal Tumors.
    Keung EZ; Raut CP
    Surg Clin North Am; 2017 Apr; 97(2):437-452. PubMed ID: 28325196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surgical intervention for imatinib and sunitinib-resistant gastrointestinal stromal tumors.
    Kikuchi H; Setoguchi T; Miyazaki S; Yamamoto M; Ohta M; Kamiya K; Sakaguchi T; Konno H
    Int J Clin Oncol; 2011 Dec; 16(6):741-5. PubMed ID: 21394667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic therapy of advanced/metastatic gastrointestinal stromal tumors: an update on progress beyond imatinib, sunitinib, and regorafenib.
    Mohammadi M; Gelderblom H
    Expert Opin Investig Drugs; 2021 Feb; 30(2):143-152. PubMed ID: 33252274
    [No Abstract]   [Full Text] [Related]  

  • 14. Rhabdomyosarcomatous differentiation in gastrointestinal stromal tumors after tyrosine kinase inhibitor therapy: a novel form of tumor progression.
    Liegl B; Hornick JL; Antonescu CR; Corless CL; Fletcher CD
    Am J Surg Pathol; 2009 Feb; 33(2):218-26. PubMed ID: 18830121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiotherapy for Gastrointestinal Stromal Tumors.
    Ozkan EE
    Chin Med J (Engl); 2018 Jan; 131(2):235-240. PubMed ID: 29336374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term survival outcome with tyrosine kinase inhibitors and surgical intervention in patients with metastatic or recurrent gastrointestinal stromal tumors: A 14-year, single-center experience.
    Kim JH; Ryu MH; Yoo C; Chae H; Na H; Beck M; Kim BS; Yoo MW; Yook JH; Kim BS; Kim KH; Kim CW; Kang YK
    Cancer Med; 2019 Mar; 8(3):1034-1043. PubMed ID: 30693663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Role of Surgery in Metastatic Gastrointestinal Stromal Tumors.
    Keung EZ; Fairweather M; Raut CP
    Curr Treat Options Oncol; 2016 Feb; 17(2):8. PubMed ID: 26820287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gastrointestinal Stromal Tumors.
    von Mehren M; Joensuu H
    J Clin Oncol; 2018 Jan; 36(2):136-143. PubMed ID: 29220298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential properties of current tyrosine kinase inhibitors in gastrointestinal stromal tumors.
    Demetri GD
    Semin Oncol; 2011 Apr; 38 Suppl 1():S10-9. PubMed ID: 21419931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peritoneal Carcinomatosis as an Initial Presentation of Gastrointestinal Stromal Tumor: A Case Report and Review of the Literature.
    Ozcan G; Gautam G; Da Cunha T; Becker EC; Perosevic N
    Cureus; 2022 Jun; 14(6):e26421. PubMed ID: 35785012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.